Nuclear receptors (NRs) are a class of proteins responsible for
thyroid hormones and sensing steroid and certain other molecules.
There are 48 genes in the human genome that code for the NRs. As
the largest family of eukaryotic transcription factors, NRs control
numerous processes involved in development, cell cycle, and
important metabolic pathways. Generally, they activate the
transcription of sets of genes in response to the binding of
cognate ligands, usually small lipophilic molecules (steroids,
vitamins, and fatty acid derivatives). Like many receptors, ligand
binding induces a conformational change in the receptor, but unique
to nuclear receptors is their ability to up- or down-regulate gene
expression. This ability makes
nuclear receptors interesting therapeutic and liability
targets.